Role of p27(Kip1) and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer

American Journal of Pathology

Volumn 153, Issue 2, 1998, Pages 505-513

  Kawana, Hidetada ^a   Tamaru, Jun Ichi ^a   Tanaka, Tomoaki ^a   Hirai, Aizan ^a   Saito, Yasushi ^a   Kitagawa, Masatoshi ^b   Mikata, Atsuo ^a   Harigaya, Kenichi ^a   Kuriyama, Takayuki ^a  

^a CHIBA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; HISTONE H1; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROTAMINE KINASE; PROTEIN P27; BIOLOGICAL MARKER; CDK2 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CELL NUCLEUS ANTIGEN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ENZYME INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; CELL DIVISION; CHEMISTRY; ENZYME IMMUNOASSAY; LUNG TUMOR; METABOLISM; MIDDLE AGED; NORTHERN BLOTTING; PATHOLOGY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; BIOLOGICAL MARKERS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 0031596172     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65593-9     Document Type: Article

References (48)

1. Schottenfeld D: Epidemiology of lung cancer. Lung Cancer: Principles and Practice. Edited by Pass H, Mitchell JB, Johnson DH, Turrisi AT. Philadelphia, Lippincott-Raven Publishers, 1996, pp 305-321
2. Minshull J: Cyclin synthesis: who needs it? (review). Bioessays 1993, 15:149-155
3. Pines J: Cyclins and cyclin-dependent kinases: take your partners (review). Trends Biochem Sci 1993, 18:195-197
4. Sherr CJ. Mammalian G1 cyclins (review). Cell 1993, 73:1059-1065
5. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM: Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 1992, 257:1689-1694
6. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994, 8:9-22
7. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994, 78:67-74
8. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 (see comments). Science 1995, 269:682-685
9. Kip1 accumulation during the cell cycle. Science 1996, 271:1861-1864
10. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994, 372:570-573
11. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilcyznski S, Lee YY, Bartram CR, Koeffler HP: Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 1995, 55: 2266-2269
12. Shiohara M, el-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B, Koeffler HP: Absence of WAF1 mutations in a variety of human malignancies. Blood 1994, 84:3781-3784
13. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 1995, 55:1206-1210
14. KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood 1995, 86:1924-1930
15. Catzavelos C, Bhatacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM: Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: prognostic implications in primary breast cancer. Nat Med 1997, 3:227-230
16. Esposito V, Baldi A, Luca A, Groger A, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M, Giordano A: Prognostic role of the cyclin-dependent inhibitor p27 in non-small cell lung cancer. Cancer Res 1997, 57:3381-3385
17. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients (see comments). Nat Med 1997, 3:222-225
18. Kawai T, Suzuki M, Kono S, Shinomiya N, Rokutanda M, Takagi K, Ogata T, Tamai S: Proliferating cell nuclear antigen and Ki-67 in lung carcinoma: correlation with DNA flow cytometric analysis. Cancer 1994, 74:2468-2475
19. Bohm J, Koch S, Gais P, Jutting U, Prauer HW, Hofler H: Prognostic value of MIB-1 in neuroendocrine tumours of the lung. J Pathol 1996, 178:402-409
20. Pujol JL, Simony J, Jolimoy G, Jaffuel D, Demoly P, Quantin X, Marty AC, Boher JM, Charpentier R, Michel FB. Hypodiploidy: Ki-67 growth fraction and prognosis of surgically resected lung cancers. Br J Cancer 1996, 74:964-970
21. Brown DC, Gatter KC: Monoclonal antibody Ki-67: its use in histopathology (review). Histopathology 1990, 17:489-503
22. Gerdes J, Lemke H, Baish H, Wacher H-H, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by monoclonal antibody Ki-67. J Immunol 1984, 133: 1710-1715
23. Gerdes J, Schwab U, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983, 31:3-20
24. Gerdes J, Schulter C, Dochrow M, Wohlenberg C, Gerlach C: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991, 138:867-873
25. Hall P, Woods A. Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet 1990, 23:505-522
26. Fontanini G, Pingitore R, Bigini D, Vignati S, Pepe S, Ruggiero A, Macchiarini P: Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Am J Pathol 1992, 141:1285-1290
27. Cattorei G, Becker M, Key G: Monoclonal antibodies against recombinant parts of Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992, 168:357-363
28. Tungekar MF, Gatter KC, Dunnhill MS, Mason DY: Ki-67 immunostaining and survival in operable lung cancer. Histopathology 1991, 19: 545-550
29. Mountain CF: A new international system for staging lung cancer. Chest 1986, 89(suppl):225S
30. World Health Organization: Histological Typing of Lung Tumors, ed 2. Geneva: World Health Organization, 1981
31. Sanchez-Beato M, Saez AI, Martinez-Montero JC, Mateo MS, Sanchez-Verde L, Villuendas R, Troncone G, Piris MA: Cyclin-dependent kinase inhibitor p27(KIP1) in lymphoid tissue: p27(KIP1) expression is inversely proportional to the proliferative index. Am J Pathol 1997, 151:151-160
32. Lloyd RV, Jin L, Qian X, Kulig E: Aberrant p27kip1 expression in endocrine and other tumors. Am J Pathol 1997, 150:401-407
33. Yamamoto K, Hirai A, Ban T, Saito J, Tahara K, Terano T, Tamura Y, Saito Y, Kitagawa M: Thyrotropin induces G1 cyclin expression and accelerates G1 phase after insulin-like growth factor I stimulation in FRTL-5 cells. Endocrinology 1996, 137:2036-2042
34. Hirai A, Nakamura S, Noguchi Y, Yasuda T, Kitagawa M, Tatsuno I, Oeda T, Tahara K, Terano T, Narumiya S, Kohn L, Saito Y: Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27kip1 and facilitate the progression from G1 to S phase in growth stimulated rat FRTL-5 cells. J Biochem 1997, 272:13-16
35. Marchetti A, Doglioni C, Barbareschi M, Buttitta F, Pellegrini S, Bertacca G, Chella A, Merlo G, Angeletti CA, Dalla Palma P, Bevilacqua G. p21 RNA, and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene 1996, 12:1319-1324
36. Kitagawa M, Okabe T, Ogino H, Matsumoto H, Suzuki-Takahashi I, Kokubo T, Higashi H, Saitoh S, Taya Y, Yasuda H, Ohba Y, Nishimura S, Tanaka N, Okuyama A: Butyrolactone I, a selective inhibitor of cdk2, and cdc2 kinase. Oncogene 1993, 8:2425-2432
37. Kitamura H, Kameda Y, Nakamura N, Nakatani Y, Inayama Y, Iida M, Noda K, Ogawa N, Shibagaki T, Kanisawa M: Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchiolo-alveolar lung carcinoma. Am J Pathol 1995, 146:876-887
38. Jordan RCK, Bradley G, Slingerland J: Reduced levels of the cell-cycle inhibitor p27(Kip1) in epithelial dysplasia and carcinoma of the oral cavity. Am J Pathol 1998, 152:585-590
39. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997, 3:231-234
40. 1a,b) invasive breast carcinomas. Cancer Res 1997, 57:1259-1263
41. Saccomano G, Archer V, Auerbach O, Saunders R, Brennan L: Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974, 33:256-270
42. Mori M, Chiba R, Takahashi T: Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Cancer 1993, 72:2331-2340
43. Miller R: Bronchiolo-alveolar adenoma. Am J Surg Pathol 1990, 14: 904-912
44. Nakanishi K: Alveolar epithelial hyperplasia and adenocarcinoma of the lung. Am J Surg Pathol 1990, 14:904-912
45. Weng S, Tsuchiya E, Satou Y, Kitagawa T, Nakagawa K, Sagano H: Multiple atypical adenomatous hyperplasia of type II pneumocytes and bronchiolo-alveolar carcinoma. Histopathology 1990, 16:101-103
46. Yamamoto H, Monden T, Ikeda K, Izawa H, Fukuda K, Fukunaga M, Tomita N, Shimano T, Shiozaki H, Monden M: Coexpression of cdk2/ cdc2 and retinoblastoma gene products in colorectal cancer. Br J Cancer 1995, 71:1231-1236
47. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, Robert JM: Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 1991, 66:1217-1228
48. Morgan DO: Principles of CDK regulation (review). Nature 1995, 374:131-134